EMA401
EMA401 is an experimental drug that is currently under investigation for its potential use in the treatment of chronic pain conditions, such as neuropathic pain. It is an angiotensin II type 2 receptor antagonist, which means it works by blocking the effects of angiotensin II, a hormone that can cause blood vessels to narrow and blood pressure to increase.
Mechanism of Action[edit]
EMA401 works by blocking the angiotensin II type 2 receptor (AT2R). Angiotensin II is a hormone that can cause blood vessels to narrow (vasoconstrict) and blood pressure to increase. By blocking the effects of angiotensin II, EMA401 may help to reduce pain.
Clinical Trials[edit]
EMA401 has been tested in several clinical trials for its potential use in treating chronic pain conditions. In a phase II clinical trial, EMA401 was found to be effective in reducing pain in patients with postherpetic neuralgia, a type of neuropathic pain that can occur after an outbreak of shingles.
Potential Uses[edit]
While EMA401 is still in the experimental stages, it has potential uses in the treatment of various chronic pain conditions, including neuropathic pain, fibromyalgia, and osteoarthritis. Further research is needed to confirm these potential uses and to fully understand the drug's mechanism of action and potential side effects.
Side Effects[edit]
As with any drug, EMA401 may have potential side effects. In clinical trials, the most common side effects reported were headache, dizziness, and fatigue. However, as EMA401 is still in the experimental stages, further research is needed to fully understand the potential side effects of this drug.
See Also[edit]
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
-
3D model of EMA401 -
Photograph of EMA401
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
